EDAN Presents Medical Imaging, Patient Monitoring, and Diagnostic Solutions

By HospiMedica International staff writers
Posted on 19 Nov 2026

Edan Instruments (Shenzhen, China) is showcasing a broad range of medical technologies at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. The company is highlighting solutions across ultrasound imaging, patient monitoring, cardiology, in vitro diagnostics (IVD), obstetrics and gynecology, and veterinary medicine. Featured products include the new Acclarix LX9S ultrasound system, iV100 patient monitor, Smart ECG Web platform, and upgraded i500 blood gas and chemistry analyzer, reflecting EDAN’s emphasis on connected healthcare and integrated clinical workflows.

Making its debut at the exhibition is the Acclarix LX9S ultrasound system, powered by EDAN's SynSight zone sonography platform. The system incorporates a new eSRI imaging algorithm designed to improve image clarity across different clinical applications. It also features a 23.8-inch display, optical trackball, and redesigned touchscreen interface to streamline operation and support diagnostic imaging workflows.


Image: Edan Instruments is showcasing technologies across ultrasound, patient monitoring, cardiology, IVD, obstetrics and gynecology, and veterinary medicine at MEDICA 2026. (Photo courtesy of Edan Instruments)

In patient monitoring, EDAN is highlighting the iV100, which functions as both a transport monitor and a multiparameter module within the iV Series. The platform supports real-time PresCCO continuous cardiac output monitoring, advanced physiological parameters, and clinical decision-support applications for critical care. In cardiology, the company's Smart ECG Web platform connects electrocardiography devices across departments and healthcare facilities, enabling centralized ECG data management, review, and reporting. EDAN is also preparing to introduce a wearable Patch Holter capable of recording ECG signals continuously for up to 14 days to help detect intermittent cardiac events.

EDAN is also presenting its i500 blood gas and chemistry analyzer, which combines benchtop testing capabilities with a compact design for critical care settings. The latest upgrade adds a co-oximetry panel and automated quality control functionality. Another featured IVD solution is the H90 Series six-part differential hematology analyzer, which incorporates reticulocyte (RET) detection to expand blood cell analysis capabilities.

The company's broader portfolio includes solutions for fetal and maternal monitoring, intrapartum imaging, endoscopy, colposcopy, and pelvic floor rehabilitation. In veterinary diagnostics, EDAN is highlighting the CC30 Vet biochemistry analysis system, which supports liver and kidney function assessment in pets through a range of testing cartridges and parameters. Through its participation at MEDICA 2026, EDAN is seeking to strengthen collaboration with international healthcare partners while presenting technologies for hospital, laboratory, and veterinary applications.

“Germany and Europe are important partners in the global healthcare industry. As China’s medical technology sector expands internationally, closer collaboration with European healthcare professionals and industry partners can create opportunities for shared progress,” said Alex You, Senior Director of Marketing, Customer Service, Global Connectivity & Integration at EDAN. “By understanding local clinical needs and translating them into accessible, reliable solutions, we can contribute to more effective healthcare. MEDICA offers a valuable opportunity to strengthen these connections and exchange perspectives.”


Latest Medica 2026 News